Capecitabine and Pseudomonas Aeruginosa Combination in Metastatic Breast Cancer (MBC)
Clinical trial NCT01380808 · COMPLETED
Trial details
- NCT number
- NCT01380808
- Sponsor
- Fudan University
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-05-01
- Primary completion
- 2013-07-01
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.